Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain

ClinicalTrials.gov ID: NCT00857415

Public ClinicalTrials.gov record NCT00857415. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 8:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Study of the Correlation Between Florbetapir F 18 (18F-AV-45) PET Imaging and Amyloid Pathology

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is designed to test the relationship between measurements of brain amyloid using florbetapir F 18 PET imaging and true levels of amyloid by dissection of the brain at autopsy. Amyloid in the brain is a key feature of Alzheimer's Disease (AD).

Study identification

NCT ID
NCT00857415
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Avid Radiopharmaceuticals
Industry
Enrollment
226 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2008 (Type not available)
Primary completion
Mar 2010 (Actual)
Completion
May 2010 (Actual)
Last update posted
May 22, 2012

2008 – 2010

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
25
Facility City State ZIP Site status
Research Site Phoenix Arizona 85006 —
Research Site Scottsdale Arizona 85258 —
Research Site Sun City Arizona 85351 —
Research Site Little Rock Arkansas 72211 —
Research Site Irvine California 92697 —
Research Site San Francisco California 94109 —
Research Site Fort Myers Florida 33912 —
Research Site Miami Florida 33137 —
Research Site Miami Beach Florida 33140 —
Research Site Miami Springs Florida 33166 —
Research Site Orlando Florida 32835 —
Research Site Sarasota Florida 34231 —
Research Site St. Petersburg Florida 33709 —
Research Site West Palm Beach Florida 33407 —
Research Site Baltimore Maryland 21221 —
Research Site Hattiesburg Mississippi 39401 —
Research Site St Louis Missouri 63141 —
Research Site Albany New York 12208 —
Research Site New Hyde Park New York 11040 —
Research Site Durham North Carolina 27710 —
Research Site Centerville Ohio 45459 —
Research Site Oklahoma City Oklahoma 73112 —
Research Site Charleston South Carolina 29425 —
Research Site Johnson City Tennessee 37614 —
Research Site Bennington Vermont 05201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00857415, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 22, 2012 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00857415 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →